ResearchEfficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension
ResearchThe Role of Cardiac Imaging for Diagnosis of Cardiac Amyloidosis: A Systematic Review and Meta-Analysis of Test Accuracy
ResearchLong-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial
May 1, 2026Journal ArticleAcoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Trial.Written by 1 Roon author & 22 others Via Journal of Cardiac Failure
May 27, 2026Journal ArticleMultimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection.Written by 1 Roon author & 29 others Via The American Heart Association Journals
ResearchIncremental Prognostic Value of Cardiac Magnetic Resonance Beyond Biomarker Staging in Transthyretin Cardiac Amyloidosis
ResearchAge-Adjusted Echocardiographic Parameters for Differentiating Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
ResearchEarly Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy
ResearchDisparities in Diagnosis and Outcomes in American Patients with Transthyretin Cardiac Amyloidosis
ResearchCardiac Amyloidosis Detection from a Single Echocardiographic Video Clip: A Novel Artificial Intelligence-Based Screening Tool
Feb 13, 2025Journal ArticleMitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study.Written by 2 Roon authors & 19 others Via Journal of Cardiac Failure